SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Unicycive Therapeutics, Inc. (UNCY) Reports $7.0M Q3 Net Loss; Cash Runway Beyond 2027

Unicycive reported a Q3 2026 net loss of $7.0M, or $0.25 per share, versus $6.0M, or $0.33 per share, in Q3 2025. Cash, cash equivalents and marketable securities were approximately $59M at September 30, with expected runway beyond 2027.Material DetailsContext by AI AnalystThis is a late-stage regu…

UNCY

Related stories